Cytovene IV and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cytovene IV and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ganciclovir
Brand name: Cytovene
Synonyms: Cytovene (injection), Cytovene-IV
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytovene IV-Insulin degludec
- Cytovene IV-Insulin Degludec (U-100) Prefilled Pens
- Cytovene IV-Insulin Degludec (U-100) Vials
- Cytovene IV-Insulin Degludec (U-200) Prefilled Pens
- Cytovene IV-Insulin degludec and liraglutide
- Cytovene IV-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cytoxan
- Insulin aspart, recombinant Subcutaneous-Cytoxan (Cyclophosphamide Injection)
- Insulin aspart, recombinant Subcutaneous-Cytoxan (Cyclophosphamide Tablets)
- Insulin aspart, recombinant Subcutaneous-Cytoxan Lyophilized
- Insulin aspart, recombinant Subcutaneous-Cytra K Oral Solution
- Insulin aspart, recombinant Subcutaneous-Cytra-2